Prescreening evaluation of a brush-based faecal immunochemical test for haemoglobin

Journal of Medical Screening

Volumn 10, Issue 3, 2003, Pages 123-128

  Young, G P ^a,b   St John, D J B ^c   Cole, S R ^b,d   Bielecki, B E ^c   Pizzey, C ^c   Sinatra, M A ^c   Polglase, A L ^e   Cadd, B ^d   Morcom, J ^d  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d REPATRIATION GENERAL HOSPITAL   (Australia)

^e CABRINI HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADENOMA; ADULT; AGED; ARTICLE; CANCER; CANCER DIAGNOSIS; CLINICAL TRIAL; COLONOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EVALUATION; FECES ANALYSIS; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MALE; MASS SCREENING; NEOPLASM; OCCULT BLOOD; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SAMPLING; SCREENING; SENSITIVITY AND SPECIFICITY;

ADENOMA; ADULT; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; DIVERTICULOSIS, COLONIC; FALSE POSITIVE REACTIONS; FECES; FEMALE; HEMOGLOBINS; HEMORRHOIDS; HUMANS; IMMUNOLOGIC TESTS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT PARTICIPATION; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 1542360052     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1258/096914103769011012     Document Type: Article

References (45)

1. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71.
2. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of fecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
3. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348:1467-71.
4. Mandel JS, Church TR, Ederer F, et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999;91:434-7.
5. Macrae FA, St John DJB, Caligiore P, et al. Optimal dietary conditions for Hemoccult testing. Gastroenterology 1982;82:899-903.
6. Feinberg EJ, Steinberg WM, Banks BL, et al. How long to abstain from eating red meat before fecal occult blood tests? Ann Intern Med 1990;113:403-4.
7. Jaffe RM, Kasten B, Young DS, et al. False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). Ann Intern Med 1975;83:824-6.
8. Greenberg PD, Cello JP, Rockey DC. Relationship of low-dose aspirin to GI injury and occult bleeding: a pilot study. Gastrointest Endosc 1999;50:618-22.
9. Hemoccult® SENSA® Product Instructions. Fullerton CA: Beckman Coulter Inc., 2002.
10. Young GP, St John DJB, Winawer SJ, et al. Choice of fecal occult blood tests for colorectal cancer screening: Recommendations based on performance characteristics in population studies. A WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol 2002;97:2499-507.
11. Adams EC, Layman KM. Immunochemical confirmation of gastrointestinal bleeding. Ann Clin Lab Sci 1974;4:343-9.
12. Barrows GH, Burton RM, Jarrett DD, et al. Immunochemical detection of human blood in feces. Am J Clin Path 1978;69:342-6
13. Saito H, Tsuchida S, Fukushi M, et al. An immunological occult blood test for mass screening of colorectal cancer by reverse passive hemagglutination (RPHA). Jap J Gastroenterol 1984;81:2831-3.
14. Young GP, St John DJB. Faecal occult blood tests: choice, usage and clinical applications. Clin Biochem Rev 1992;13:161-7.
15. Young GP, St John DJB. Selecting an occult blood test for use as a screening tool for large bowel cancer. Front Gastrointest Res 1991;18:135-56.
16. Rockey DC, Auslander A, Greenberg PD. Detection of upper gastrointestinal blood with fecal occult blood tests. Am J Gasroenterol 1999;94:344-50.
17. Allison JE, Tekawa IS, Ransom LJ, et al. A comparison of fecal occult blood tests for colorectal cancer screening. N Engl J Med 1996;334:154-9.
18. Adlercreutz H, Partanen P, Virkola P, et al. Five guaiac-based tests for occult blood in faeces compared in vitro and in vivo. Scand J Clin Lab Invest 1984;44:519-28.
19. St John DJB, Young GP, Alexeyeff MA, et al. Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology 1993;104:1661-8.
20. Levin B, Hess K, Johnson C. Screening for colorectal cancer: a comparison of 3 fecal occult blood tests. Arch Intern Med 1997;157:970-6.
21. King J, Fairbrother G, Thompson C, et al. Colorectal cancer screening: Optimal compliance with postal faecal blood test. Aust N Z J Surg 1992;62:714-9.
22. Joseph A. Compliance with fecal occult blood testing: the role of restrictive diets. Am J Public Health 1988;78:839-41.
23. Robinson MHE, Pye G, Thomas WM, et al. Haemoccult screening for colorectal cancer: the effect of dietary restriction on compliance. Europ J Surg Oncol 1994;20:545-8.
24. Cole SR, Young GP. Effect of dietary restriction on participation in faecal occult blood test screening for colorectal cancer. Med J Aust 2001;175:195-8.
25. Weller DP, Owen N, Hiller JE, et al. Colorectal cancer and its prevention: prevalence of beliefs, attitudes, intentions and behaviour. Aust J Pub Health 1995;19:19-23.
26. Myers RE, Vernon SW, Tilley BC, et al. Intention to screen for colorectal cancer among white male employees. Prev Med 1998;27:279-87.
27. Li T, Nakama H, Wei N. Reasons for non-compliance in colorectal cancer screening with fecal occult blood test. Eur J Med Res 1998;3:397-400.
28. Frew E, Wolstenholme J, Whynes D. Mass population screening for colorectal cancer: factors influencing subjects' choice of screening test. J Health Serv Res Policy 2001;6:85-91.
29. Ahlquist DA, Schwartz S, Isaacson J, et al. A stool collection device: the first step in occult blood testing. Ann Intern Med 1988;108:609-12.
30. Nakama H, Fattah A, Zhang B, et al. A comparative study of immunochemical fecal tests for detection of colorectal adenomatous polyps. Hepato-Gastroenterol 2000;47:386-9.
31. Nakama H, Kamijo N, Miyata K, et al. Sensitivity and specificity of several immunochemical tests for colorectal cancer. Hepato-Gastroenterol 1998;45:1579-82.
32. Saito H, Soma Y, Nakajima M, et al. A case-control study evaluating occult blood screening with Hemoccult test and on immunochemical hemagglutination test. Oncol Reports 2000;7:815-9.
33. Young GP, Macrae FA, St John DJB. Clinical methods of early detection: basis, use and evaluation. In: Young GP, Levin B, Rozen P, eds. Prevention and early detection of colorectal cancer. London: WB Saunders, 1996:241-70.
34. Rozen P, Knaani J, Samuel Z. Comparative screening with a sensitive guaiac and specific immunochemical occult blood test within an endoscopy study. Cancer 2000;89:46-52.
35. Gardner MJ, Altman DG. Confidence intervals rather than P values: estimation rather than hypothesis testing. BMJ 1986;292:746-50.
36. Whynes DK, Walker AR, Hardcastle JD. Cost-effective screening strategies for colorectal cancer. J Pub Health Med 1992;14:43-9.
37. Rasmussen M, Kronborg O. Upper gastrointestinal cancer in a population-based screening program with fecal occult blood test for colorectal cancer. Scand J Gastroenterol 2001;37:95-8.
38. Young GP. Screening for colorectal cancer: alternative faecal occult blood tests. Eur J Gastroenterol Hepatol 1998;10:205-212.
39. Rozen P, Knaani J, Samuel Z. Performance characteristics and comparison of two immunochemical and two guaiac faecal occult blood screening tests for colorectal neoplasia. Dig Dis Sci 1997;42:2064-71.
40. Rozen, P, Knaani J, Samuel Z. Eliminating the need for dietary restrictions when using a sensitive guaiac faecal occult blood test. Dig Dis Sci 1999;44:756-60.
41. Nakama H, Fattah ASMA, Zhang B, et al. A comparative study of immunochemical faecal tests for detection of colorectal adenomatous polyps. Hepato-Gastroenterol 2000;47:386-9.
42. Nakama H, Kamijo N, Miyata K, et al. Sensitivity and specificity of several immunochemical tests for colorectal cancer. Hepato-Gastroenterol 1998;45:1579-82.
43. Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992;326:658-62
44. Macrae FA, St John DJB. Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology 1982;82:891-8.
45. Vernon S. Participation in colorectal cancer screening: a review. J Natl Cancer Inst 1997;89:1406-22.